Huge News! FDA Approves Cannabis Derived Medication For First Time Ever


A recently published study indicates that CBD has significant benefits for those living with epilepsy, helping inform policymakers

For the estimated 65 million people living with epilepsy, even the simplest things in life can become a considerable challenge. The neurological disorder is caused by erratic nerve cell activity in the brain. This most commonly results in seizures of varying degrees of severity. People diagnosed with epilepsy are almost always prohibited from doing everyday activities such as driving, and in more severe cases, the seizures can take over virtually every aspect of their lives.

While there are medications that have proven useful for some, for many others these traditional methods have been less than ideal. Those dealing with stubborn versions of the debilitating condition have been waiting a very long time for a new way to reduce the impact of seizures on their lives. That’s why it was so fantastic to see a long-term CBD study finally published recently. This new report even helped gain FDA approval for a new CBD medication called Epidiolex, marking the first time the FDA has formally approved a marijuana-derived drug.

New CBD Study

The newly published CBD study has been in the works for several years now, starting back in 2015. Conducted by researchers at the University of Alabama at Birmingham, the report was finally finished and published in the Epilepsy and Behavior journal earlier this month. The team set out to understand better the effect of CBD oil on the severity and frequency of seizures of patients for whom traditional medications proved ineffective. The participants were given between 5mg and 50mg of CBD oil daily and told to track their seizure patterns. Their pool included 72 children along with 60 adults who would be checked up on at 12, 24, and 48-week intervals.

After collecting all their data, the team started to analyze the findings for important trends. Of the 132 patients studied, over two-thirds reported a significant reduction in the frequency of seizures. Looking closer the majority of the improvement happened over the first 12 weeks. For example, after week 12 the average number of bi-weekly seizures dropped from 144 to just 52. The severity of seizures also went down, as after 12 weeks participants reported a drop from 80.7 to only 39.2 on the Chalfont Seizure Severity Scale.

FDA Approval

The drug used in testing, Epidiolex, recently became the first cannabis-derived drug to earn FDA approval. While this technically happened before the results were made public, back on June 25th, the bottom line is that research like this is precisely why the FDA was finally willing to back CBD oil. It’s even been approved for treatment of two particularly hard types of epilepsy to manage, Lennox-Gastaut syndrome and Dravet syndrome. This push for approval has been gaining traction over the last several years as more people become aware of the many benefits of CBD oil.

A comprehensive report published last July was one of the first to use long-term evidence to support the power of CBD. This 22-page study asked over 2,400 individuals about their experiences and changes after starting to take CBD oil. Likely the most compelling result was that a full 42% of those surveyed said they had been able to stop taking at least one other medication thanks to the improvements associated with CBD. What’s even better for us vapers out there is that evidence shows vaping is by far the most efficient way to consume your CBD. For example, taken orally you only receive about 15% of the potential CBD, but with vaping the number jumps all the way to 60%, a full four times more effective.


If you or anyone you know deals with epilepsy, you know just how much it can affect day to day life. From not being able to drive to sometimes needing near-constant supervision, living with seizures can be very tough. That’s why it’s so great to see more research indicating the extreme harm reduction and seizure frequency reduction value of CBD oil. This latest rush of CBD evidence can be associated with how popular the substance has become among alternative medicine circles. This popularity has helped more research get funding, which is, in turn, legitimizing the cannabis-derived drug.

What’s even better for us vapers is how much more efficient vaped CBD is compared with CBD took orally. Given what we now know thanks to these reports, the effectiveness of CBD could be as much as four times higher when vaped compared with pill form. That’s why it’s important to keep spreading not only data on CBD but also how vaping improves it. If vaping CBD can become the go-to method of treating epilepsy, it would be a massive victory for the public perception of vaping. Regardless though, we need more research conducted on the topic. After all, if vaping can help improve the lives of those with epilepsy, then we should be striving to learn everything we can.

Did you know that CBD oil is so effective at helping epilepsy patients? Do you think these findings will help improve the public perception of vaping overall? How can we help spread the positive information on vaping? Let us know what you think in the comments, and don’t forget to check back here or join our Facebook and Twitter communities for more news and articles.

Dustin has been vaping for almost a decade. He found e-cigarettes in 2008 and quickly became drawn to them as an early adopter. He's been writing reviews ever since and has established himself as a well-versed authority on the subject.

You may also like...

1 Response

  1. Deb Harpster says:

    awesome. Now they need to look into it for all neurological disorders like parkinsons and tourettes.

Leave a Reply

Your email address will not be published. Required fields are marked *